Vectus Biosystems Ltd - Asset Resilience Ratio

Latest as of December 2023: 2.18%

Vectus Biosystems Ltd (VBS) has an Asset Resilience Ratio of 2.18% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read VBS total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

AU$70.00K

≈ $49.53K USD Cash + Short-term Investments

Total Assets

AU$3.21 Million

≈ $2.27 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2020)

This chart shows how Vectus Biosystems Ltd's Asset Resilience Ratio has changed over time. See Vectus Biosystems Ltd book value and equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Vectus Biosystems Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Vectus Biosystems Ltd (VBS) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$70.00K	2.18%
Total Liquid Assets	AU$70.00K	2.18%

Asset Resilience Insights

Limited Liquidity: Vectus Biosystems Ltd maintains only 2.18% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Vectus Biosystems Ltd Industry Peers by Asset Resilience Ratio

Compare Vectus Biosystems Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Argen-X F:1AE	Biotechnology	25.67%
Tubize-Fin BR:TUB	Biotechnology	0.05%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
Dashenlin Pharm Grp Co Ltd SHG:603233	Biotechnology	0.02%
Staidson Beijing Biopharma SHE:300204	Biotechnology	7.93%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	41.25%
Ardelyx Inc NASDAQ:ARDX	Biotechnology	41.14%
Xiangxue Pharmaceutical SHE:300147	Biotechnology	0.05%

Annual Asset Resilience Ratio for Vectus Biosystems Ltd (2013–2020)

The table below shows the annual Asset Resilience Ratio data for Vectus Biosystems Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2020-06-30	90.60%	AU$2.72 Million ≈ $1.92 Million	AU$3.00 Million ≈ $2.12 Million	+4.48pp
2016-06-30	86.11%	AU$4.03 Million ≈ $2.85 Million	AU$4.68 Million ≈ $3.31 Million	+85.82pp
2015-06-30	0.29%	AU$33.99K ≈ $24.05K	AU$11.73 Million ≈ $8.30 Million	-77.53pp
2013-06-30	77.82%	AU$1.16 Million ≈ $821.49K	AU$1.49 Million ≈ $1.06 Million	--

pp = percentage points

About Vectus Biosystems Ltd

AU:VBS Australia Biotechnology

Market Cap

$4.16 Million

AU$5.88 Million AUD

Market Cap Rank

#28694 Global

#1627 in Australia

Share Price

AU$0.11

Change (1 day)

-8.33%

52-Week Range

AU$0.04 - AU$0.44

All Time High

AU$2.00